Digital It’s time for more tech and biotech innovation in 2023 The drive to make the UK a ‘scientific powerhouse’ was central to the government’s
Views & Analysis Addressing leadership barriers for women in tech and pharma Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
